• Alcidion celebrates 25 years of transforming healthcare with proactive, smart, intuitive technology solutions
• FY25 saw record financial results, including 10% revenue growth, 31% ARR growth, and $5.1M in underlying EBITDA
• Secured $73.8M in new contract value, including a landmark $39M EPR contract with North Cumbria NHS Trust

Alcidion Group Limited (ASX: ALC) presented its 2025 Annual General Meeting Chair Address and Presentation, highlighting the company's 25-year journey of transforming healthcare with proactive, smart, and intuitive enterprise technology solutions. The company's purpose is to address the most complex operational and clinical needs of hospitals and care systems across its key markets of the UK, Australia, and New Zealand. Alcidion's flagship product, Miya Precision, is a modular, cloud-native platform that delivers real-time, AI-enabled clinical decision support, interoperability, and intuitive data visualisation. FY25 was a record-setting year for Alcidion, with total revenue of $40.8 million, up 10% year-on-year, and Annual Recurring Revenue now standing at $28.5 million, up 31%. The company secured $73.8 million in new contract value, more than double the previous period, including a landmark, 10-year $39 million North Cumbria NHS Trust Electronic Patient Record (EPR) contract. Alcidion's financial discipline and robust platform have enabled continued investment in innovation, market expansion, and shareholder value creation. As the company moves into FY26, it enters the year with $34 million already secured in contracted revenue and a strong pipeline, positioning it for sustained growth, innovation, and impact in the global healthcare market.

Alcidion expects to generate $34 million in contracted revenue for the 2026 financial year, excluding anticipated contract wins, underpinned by its strong pipeline and expanding installed base.

Alcidion is focused on driving continued organic growth in established markets, evolving its product with deeper AI capabilities, targeting new territories like Canada and the Middle East, and exploring adjacencies such as aged care and community health, while maintaining disciplined execution and agile responsiveness to market opportunities.